Access to Novel Medicines Platform - Terms of reference of the WHO Regional Office for Europe
27 February 2024
| Meeting report
Overview
These terms of reference apply to the newly established WHO Regional Office for Europe Access to Novel Medicines Platform, which is intended to provide a framework for collaboration between WHO, Member States, non-State actors and other partner organizations to improve patient access to novel, high-cost medicines in the WHO European Region.
WHO Team
WHO Europe Access to Novel Medicines Platform
